Pain Management

IBH expands pain and opioid treatment program in workers compensation plans

Integrated Behavioral Health (IBH) is excited to announce the expansion of and enhancements to its pain and opioid treatment program for injured workers covered in a workers compensation plan.  Providing management and programs for early intervention and chronic opioid use treatment, IBH utilized its 30-year history of successfully treating opioid patients to build a specialized,… Read more »

PainCAS partners with Allscripts to make software available to EHR users

Pain and opioid risk assessment featuring SOAPP® & COMM® to be available through Allscripts Developer Program WALTHAM, Mass., July 2, 2018  — Inflexxion, Inc. announced today that its pain and opioid risk assessment software, PainCAS, is being featured as the Allscripts Developer Program (ADP) July app of the month.  PainCAS enables Allscripts ambulatory EHR users to… Read more »

A New Strategy for Combating the Opioid Epidemic

The Department of Health and Human Services (HHS) recently released their 5-point strategy for combating the opioid crisis. The strategy outlines the elements the HHS deems most important in targeting the epidemic at its source and ending the fight for the many thousands still struggling. The team here at Inflexxion is working to help achieve… Read more »

Marijuana: a dangerous, addictive drug or relief for pain patients?

Marijuana was valued for its healing powers in many ancient cultures. In ancient Greece, cannabis cured inflammation. In India, it was offered as a cure for leprosy. In China, it was used for just about everything. By 1850, marijuana was listed in the United States Pharmacopeia and was considered acceptable for use in curing many… Read more »

Disability Claimants and the Implementation of a Web-Based Pain Assessment/Pain Management Program

How important is a pain management program in the clinical setting? Recently, Inflexxion partnered with Aetna Disability to answer this question, exploring the impact of using a clinical assessment system and pain management resources with disability claimants as part of a pain management program. Two of Inflexxion’s tools were implemented, PainCAS Clinical Assessment System, a… Read more »

Your questions about the COMM-9 answered

►What is the COMM-9? The COMM-9 is an evidence-based electronically administered clinical screening tool intended to identify and monitor aberrant opioid-related behavior in chronic pain patients on opioid therapy. It is a brief version of the Current Opioid Misuse Measure (COMM). The COMM and COMM-9 were developed with guidance from pain and addiction experts and… Read more »

Your questions about the SOAPP-8 answered

What is the SOAPP-8? Broadly defined, the SOAPP-8 is a clinical tool used to determine a patient’s level of risk of misusing their opiate medication and the level of monitoring a patient on long-term opioid therapy may require. It was developed based on expert consensus regarding qualities likely to predict a patient’s risk of displaying… Read more »

Medication-assisted treatment: a solution or substitution?

Though thoroughly researched and validated as a highly effective means of treatment for those fighting opioid addiction, medication-assisted treatment, commonly abbreviated as MAT, faces opposition from the public, health professionals, and sometimes patients themselves. In May of 2017, Secretary of Health and Human Services Tom Price said about medication-assisted treatment, “if we’re just substituting one… Read more »

Disability Claimants and the Implementation of a Web-based Pain Assessment/Pain Management Program

Based on a recent study, our team has published an article in the “PAINWeek Journal” titled, “Disability Claimants and the Implementation of a Web-based Pain Assessment/Pain Management Program.” For more information about this study, please see the abstract below.  To obtain the full article, click here. Abstract One of the most frustrating aspects of a clinician’s work is getting… Read more »

Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9

Stacey A McCaffrey, PhD, Ryan A Black, PhD, Albert J Villapiano, EdD, Robert N Jamison, PhD, Stephen F Butler, PhD Pain Medicine, pnx311, https://doi.org/10.1093/pm/pnx311 Published: 11 December 2017   Abstract Objective The Current Opioid Misuse Measure (COMM) is a commonly used self-report instrument to identify and monitor aberrant opioid-related behavior in chronic pain patients on opioid therapy. However, the length… Read more »